The Multinational Postmarketing Observational Study of Women Prescribed Intrinsa.

Trial Profile

The Multinational Postmarketing Observational Study of Women Prescribed Intrinsa.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs Estrogen; Testosterone
  • Indications Female sexual dysfunction; Hormone deficiency
  • Focus Adverse reactions
  • Acronyms EMPOWER
  • Most Recent Events

    • 27 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Jun 2012 as reported by ClinicalTrials.gov record.
    • 01 Nov 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 25 Oct 2011 Additional trial acronym EMPOWER identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top